The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Sep. 15, 2015

Filed:

Oct. 15, 2010
Applicants:

Bernard Moss, Bethesda, MD (US);

Linda S. Wyatt, Rockville, MD (US);

Patricia L. Earl, Chevy Chase, MD (US);

Inventors:

Bernard Moss, Bethesda, MD (US);

Linda S. Wyatt, Rockville, MD (US);

Patricia L. Earl, Chevy Chase, MD (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C12N 15/86 (2006.01); C12N 15/863 (2006.01); C12N 7/00 (2006.01); C07K 14/005 (2006.01); A61K 39/285 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
C12N 15/86 (2013.01); C07K 14/005 (2013.01); C12N 7/00 (2013.01); C12N 15/8636 (2013.01); A61K 39/285 (2013.01); A61K 2039/5256 (2013.01); C12N 2710/24143 (2013.01); C12N 2740/16122 (2013.01); C12N 2740/16222 (2013.01);
Abstract

The present invention relates to recombinant modified vaccinia Ankara (MVA) virus containing restructured sites useful for the integration of heterologous nucleic acid sequences into an intergenic region (IGR) of the virus genome, where the IGR is located between two adjacent, essential open reading frames (ORFs) of the vaccinia virus genome, wherein the adjacent essential ORFs are non-adjacent in a parental MVA virus used to construct the recombinant MVA virus, and to related nucleic acid constructs useful for inserting heterologous DNA into the genome of a vaccinia virus, and further to the use of the disclosed viruses as a medicine or vaccine.


Find Patent Forward Citations

Loading…